Show
Sort by
-
- Journal Article
- A1
- open access
Specific descriptions of axial involvement are associated with radiographic damage development after 2 years in psoriatic arthritis patients
-
- Journal Article
- A1
- open access
Did we overreact? Insights on COVID-19 disease and vaccination in a large cohort of immune-mediated inflammatory disease patients during sequential phases of the pandemic (the BELCOMID study)
-
- Journal Article
- A1
- open access
Extent of axial damage in psoriatic arthritis and spondyloarthritis : comparative data from the BEPAS and (Be-)GIANT multicentre cohorts
-
- Journal Article
- A1
- open access
Cardiovascular comorbidities in psoriatic arthritis : epidemiology and risk factors in two different European populations
-
- Journal Article
- A1
- open access
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study
-
- Journal Article
- A1
- open access
Real-world efficacy and safety of apremilast in Belgian patients with psoriatic arthritis : results from the prospective observational APOLO study
-
The burden of psoriatic arthritis in the biologics era : data from the Belgian Epidemiological Psoriatic Arthritis Study
-
- Journal Article
- A1
- open access
Responses to 'Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain : a double-blind multicenter randomized placebo controlled three-arm study' : authors’ reply
-
Efficacy of bio-optimised curcuma extract (FLEXOFYTOL®) for painful knee osteoarthritis : data from copra, a multicenter randomised controlled study
-
- Journal Article
- A1
- open access
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target : 2017 update of recommendations by an international task force